Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers
about
Progress in the experimental therapy of severe arenaviral infectionsAmphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral EntryAccelerated and improved quantification of lymphocytic choriomeningitis virus (LCMV) titers by flow cytometryInhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants.Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses.Novel approaches in anti-arenaviral drug developmentEmerging antivirals for the treatment of hepatitis B.Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytesTherapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.Amphipathic DNA polymers exhibit antiherpetic activity in vitro and in vivo.Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection.Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.Current drug discovery strategies against arenavirus infections.Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever.Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo.Ribavirin can be mutagenic for arenaviruses.Determining the Virus Life-Cycle Stage Blocked by an Antiviral.Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.Gumming up the works: DNA polymers as HCV entry inhibitors.Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro.
P2860
Q27024953-E5F11448-8809-401C-8479-A29CCDF6BF5BQ27490785-4B21CE4F-3406-49DF-A390-8DB3449B4A97Q28729901-273B0AB2-BDE3-46FB-82CE-86456F144B3CQ33458341-A6BD75F0-15B7-495E-B6ED-EF736D61FC16Q33558767-C2B3F24A-075D-401C-A79E-4C42C1A3C051Q33779739-A4FD794B-58A8-46FD-86ED-50D07E2537F0Q33801328-F956183D-6402-4674-9BCB-CEDD6C1A64B9Q33821878-8C7154C2-B4C6-4ECC-90C0-DF67E77AD701Q35839139-7F559462-8B1B-425A-B917-B1A8F99784BAQ36804032-8A2E242C-3946-4A9D-A361-FE72A76DB0DBQ37477905-41D9B0AD-7FCC-4811-9CE8-ABF9DCF57E62Q37912497-927946D4-2982-4428-B6B1-2121F28F4DC8Q38067504-0A0E3B4F-F9B2-47C7-9A91-E98AFF7E4976Q38069359-14A7CB22-7129-47FF-A86D-EE633CCB4FADQ39368000-7ED1D260-A8ED-41FC-86EB-9120873442BBQ39544616-4582956A-1264-4981-98CD-CFFFA5A8F42FQ41922323-B101FB96-0ED4-48A9-9272-4AB9E9D56675Q42207445-5EC928B5-F9A0-4AC3-A807-21C4BAA72CB4Q42277109-70AAFAA7-863D-4198-9795-8BDE5E761BF7Q42426768-15D85BE4-2F5F-43EA-8822-3D313FB2E55EQ45323707-D89EFA77-CE17-40B2-BD17-199E747421DC
P2860
Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Inhibition of cellular entry o ...... us by amphipathic DNA polymers
@ast
Inhibition of cellular entry o ...... us by amphipathic DNA polymers
@en
type
label
Inhibition of cellular entry o ...... us by amphipathic DNA polymers
@ast
Inhibition of cellular entry o ...... us by amphipathic DNA polymers
@en
prefLabel
Inhibition of cellular entry o ...... us by amphipathic DNA polymers
@ast
Inhibition of cellular entry o ...... us by amphipathic DNA polymers
@en
P2093
P2860
P1433
P1476
Inhibition of cellular entry o ...... us by amphipathic DNA polymers
@en
P2093
Andrew M Lee
Andrew Vaillant
Anette Gundersen
Jean-Marc Juteau
Jillian M Rojek
P2860
P304
P356
10.1016/J.VIROL.2007.10.016
P407
P577
2007-11-26T00:00:00Z